SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

Strike while the ion is hot: Metrion targets demand for cardiac risk testing

19-May-2015 - Making sure candidate drugs are free of cardiac risks means drug industry demand for ion channel screening expertise is growing according to new CRO, Metrion.

Xention aims to cash in ion channel knowhow through new CRO

18-May-2015 - Heart drug developer Xention has launched a contract screening business designed for drug industry customers seeking ion channel services.

Charles River looks to save $35m from new efficiency initiatives

07-May-2015 - As competition and pricing get fiercer for CRO Charles River Laboratories, the company is looking to save about $35m from new efficiencies in its RMS (Research Models and Services) business,...

News in brief

QPS adds new in vitro dermatology and transdermal research lab in North Dakota

06-May-2015 - Full-service CRO QPS Holdings has opened its new in vitro dermatology and transdermal research laboratory in Fargo, North Dakota. 

Scientists target Hep C virus using CRISPR-Cas technology

05-May-2015 - Scientists in the US have used the CRISPR-Cas system to target the RNA of hepatitis C virus (HCV).

Roundup of CRO partnerships, offerings and other news

04-May-2015 - A number of small, mid-sized and large CROs (contract research organizations) and other companies tied to the world of clinical research have announced various partnerships and other financial moves over...

News in brief

Charles River stock falls nearly 10% on soft quarterly results

30-Apr-2015 - Charles River Laboratories saw only slight growth in revenue compared to the same quarter last year, which was driven by its safety assessment and endotoxin and microbial detection businesses, and...

Thermo Fisher to offer clients Horizon's X-MAN cell line tech

24-Apr-2015 - Thermo Fisher has added X-MAN cell line services to its biopharma R&D offerings through a supply agreement with Horizon Discovery Group.

Merck 'bio-inks' deal to use Organovo's 3D printed liver for preclinical studies

23-Apr-2015 - Merck & Co. has struck a deal with Organovo to use a 3D printed human liver system for toxicology testing as a supplement to in vitro and preclinical animal testing....

HLS and Harlan create hairless mouse model

20-Apr-2015 - Huntingdon Life Sciences and Harlan Laboratories have launched a highly immunocompromised hairless mouse model for oncology and immunology research.

Russia sees slight dip in clinical trial approvals in Q1 2015

15-Apr-2015 - The Ministry of Health of the Russian Federation approved 151 total clinical studies in Q1 of 2015, which is 11% less than the same quarter last year, though by comparison,...

AstraZeneca inks two research partnerships with PatientsLikeMe, Lead Discovery Center

14-Apr-2015 - With an eye on early-phase research, AstraZeneca has signed two deals – a five-year agreement to gain access to PatientsLikeMe’s network, and a three-year alliance with the Lead Discovery Center.

Eisai inks R&D Genomics data deal; cuts 25% US jobs

13-Apr-2015 - Eisai has inked a deal with a genome analytics firm to aid drug discovery days after announcing it would be cutting 25% of its in-house US workforce.

Takeda looks to BioXcel to help repurpose old assets for new rare disease indications

09-Apr-2015 - Takeda’s development center in the US has agreed to partner with BioXcel, a cloud-based big data solution provider, to repurpose old medicines to help treat rare diseases. 

Preclinical consolidation: MSI firm Protea buys CRO vivoPharm

08-Apr-2015 - Molecular imaging company Protea Biosciences has acquired CRO vivoPharm in the latest instance of consolidation in the preclinical sector.

Sanofi, Schrödinger forge up to $120m drug discovery deal

03-Apr-2015 - Computational drug designer Schrödinger has entered into a five-year early drug discovery collaboration with Sanofi in which Schrödinger will provide target analysis and validation to lead identification and lead optimization...

Venn seeks drug industry customers for skin substitute used to test cosmetics

03-Apr-2015 - London-listed CRO Venn Life Sciences hopes partnering with academics will help generate drug industry interest in its recently expanded skin model tech business.

UK politician pledge would ban 89% of animal research, say scientists

31-Mar-2015 - British MPs have signed an anti-animal cruelty pledge which scientists warn would “cripple” disease research and outlaw 89% of preclinical animal research.

Drug safety, crop protection and animal testing alternatives mulled at SOT

30-Mar-2015 - Employee safety is a focus for drugmakers and a growing market for the preclinical testing services sector according to Huntingdon Life Sciences.

PETA joins preclinical CROs at SOT to promote animal testing alternatives

27-Mar-2015 - Testing the toxicity of drug candidates in animals is archaic and unreliable according to PETA, which joined preclinical CROs at SOT to put forward alternatives.

Nottingham’s CRO forest thriving: UK Contractors tout new collaboration model

25-Mar-2015 - Some drug industry sponsors shy away from “jack of all trades” contractors according to a recently formed UK CRO network which says smaller firms with specific expertise can win market...

Ebola, eCigarettes and microbiomes: Hot topics at Society of Toxicology annual meeting

24-Mar-2015 - Ebola, electronic cigarettes and microbiomes are opportunities for the preclinical research sector according to delegates at a US industry conference this week.

Harvard-MIT institute partners with Google-backed Calico to study aging-related diseases

18-Mar-2015 - The Broad Institute of MIT and Harvard has entered into a partnership with Calico to study the biology and genetics of aging as part of early-stage drug discovery efforts. 

Animal rights protests have had little impact on preclinical services sector say CROs

17-Mar-2015 - Animal rights protests have not hurt the non-clinical services sector according to leading CROs which say vital drug development work has continued.

Altasciences allies with nonclinical service org to offer more complete early development tools

10-Mar-2015 - Early phase clinical research service provider Altasciences is forming a strategic alliance with ITR Laboratories, a nonclinical services organization, to help more mutual clients customize their drug development programs from...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...